The U.S. Food and Drug Administration on Monday granted accelerated approval to Pfizer’s https://www.reuters.com/markets/companies/PFE.N” target=”_blank” rel=”noopener”>(PFE.N) therapy for treating patients with a type of blood cancer that is difficult to treat…
Read More
About The Author
